Carr Douglas's most recent trade in Century Therapeutics Inc was a trade of 296 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Aug. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 04 Aug 2025 | 296 | 405,686 | - | 0.5 | 158 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 4,904 | 405,982 | - | 0.6 | 3,050 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 05 May 2025 | 295 | 410,886 | - | 0.5 | 162 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 95,625 | 95,625 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 95,625 | 411,181 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 1,240 | 315,556 | - | 0.6 | 763 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 351 | 316,796 | - | 0.8 | 274 | Common Stock |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 01 Nov 2024 | 16,611 | 317,430 | - | 1.3 | 20,930 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 01 Nov 2024 | 283 | 317,147 | - | 1.2 | 347 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 05 Aug 2024 | 289 | 334,041 | - | 1.8 | 528 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 07 Jun 2024 | 17,007 | 334,330 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 03 May 2024 | 257 | 317,323 | - | 3.1 | 798 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 07 Mar 2024 | 81,000 | 81,000 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 07 Mar 2024 | 14,000 | 317,580 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Carr Douglas | SVP Finance & Operations | 05 Feb 2024 | 643 | 304,137 | - | 3.8 | 2,470 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 05 Feb 2024 | 557 | 303,580 | - | 4.5 | 2,499 | Common Stock | |
| Century Therapeutics Inc | Douglas Carr | SVP Finance & Operations | 15 May 2023 | 120,846 | 321,391 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 7,500 | 200,545 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | VP Finance & Operations | 02 Feb 2023 | 7,500 | 193,045 | - | 0 | Common Stock | ||
| Century Therapeutics Inc | Douglas Carr | VP of Finance and Operations | 25 Jan 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |